Lung Macrophage Phenotypes and Functional Responses: Role in the Pathogenesis of COPD
Abstract
:1. Introduction
2. Lung Macrophages (LM) Phenotypes
3. LM Functional Responses
4. Macrophages in Chronic Obstructive Pulmonary Disease (COPD)
5. LMs and Bacterial Colonization of COPD Airways
6. Macrophage Phenotypes in COPD
7. Phagocytic and Efferocytic Functions of Macrophages in COPD
8. Therapeutic Targeting of Macrophages in COPD
9. Conclusions
Acknowledgments
Conflicts of Interest
References
- Guilliams, M.; De Kleer, I.; Henri, S.; Post, S.; Vanhoutte, L.; De Prijck, S.; Deswarte, K.; Malissen, B.; Hammad, H.; Lambrecht, B.N. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J. Exp. Med. 2013, 210, 1977–1992. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- van Furth, R.; Cohn, Z.A.; Hirsch, J.G.; Humphrey, J.H.; Spector, W.G.; Langevoort, H.L. The mononuclear phagocyte system: A new classification of macrophages, monocytes, and their precursor cells. Bull. World Health Organ. 1972, 46, 845–852. [Google Scholar] [PubMed]
- Epelman, S.; Lavine, K.J.; Beaudin, A.E.; Sojka, D.K.; Carrero, J.A.; Calderon, B.; Brija, T.; Gautier, E.L.; Ivanov, S.; Satpathy, A.T.; et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 2014, 40, 91–104. [Google Scholar] [CrossRef] [PubMed]
- Wynn, T.A.; Chawla, A.; Pollard, J.W. Macrophage biology in development, homeostasis and disease. Nature 2013, 496, 445. [Google Scholar] [CrossRef] [PubMed]
- Jenkins, S.J.; Ruckerl, D.; Cook, P.C.; Jones, L.H.; Finkelman, F.D.; van Rooijen, N.; MacDonald, A.S.; Allen, J.E. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 2011, 332, 1284–1288. [Google Scholar] [CrossRef] [PubMed]
- Mills, C.D.; Kincaid, K.; Alt, J.M.; Heilman, M.J.; Hill, A.M. M-1/M-2 macrophages and the TH1/TH2 paradigm. J. Immunol. 2000, 164, 6166–6173. [Google Scholar] [CrossRef] [PubMed]
- Mantovani, A.; Sica, A.; Sozzani, S.; Allavena, P.; Vecchi, A.; Locati, M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25, 677–686. [Google Scholar] [CrossRef] [PubMed]
- Novak, M.L.; Koh, T.J. Macrophage phenotypes during tissue repair. J. Leukoc. Biol. 2013, 93, 875–881. [Google Scholar] [CrossRef] [PubMed]
- Qian, B.Z.; Pollard, J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141, 39–51. [Google Scholar] [CrossRef] [PubMed]
- Goto, Y.; Ishii, H.; Hogg, J.C.; Shih, C.H.; Yatera, K.; Vincent, R.; van Eeden, S.F. Particulate matter air pollution stimulates monocyte release from the bone marrow. Am. J. Respir. Crit. Care Med. 2004, 170, 891–897. [Google Scholar] [CrossRef] [PubMed]
- van Eeden, S.F.; Tan, W.C.; Suwa, T.; Mukae, H.; Terashima, T.; Fujii, T.; Qui, D.; Vincent, R.; Hogg, J.C. Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am. J. Respir. Crit. Care Med. 2001, 164, 826–830. [Google Scholar] [CrossRef] [PubMed]
- Anderson, J.M.; Rodriguez, A.; Chang, D.T. Foreign body reaction to biomaterials. Semin. Immunol. 2008, 20, 86–100. [Google Scholar] [CrossRef] [PubMed]
- Champion, J.A.; Mitragotri, S. Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. USA 2006, 103, 4930–4934. [Google Scholar] [CrossRef] [PubMed]
- Refai, A.K.; Textor, M.; Brunette, D.M.; Waterfield, J.D. Effect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines. J. Biomed. Mater. Res. A 2004, 70, 194–205. [Google Scholar] [CrossRef] [PubMed]
- Ali, F.; Lee, M.E.; Iannelli, F.; Pozzi, G.; Mitchell, T.J.; Read, R.C.; Dockrell, D.H. Streptococcus pneumoniae-associated human macrophage apoptosis after bacterial internalization via complement and Fcgamma receptors correlates with intracellular bacterial load. J. Infect. Dis. 2003, 188, 1119–1131. [Google Scholar] [CrossRef] [PubMed]
- O’Neill, L.A.; Golenbock, D.; Bowie, A.G. The history of toll-like receptors—Redefining innate immunity. Nat. Rev. Immunol. 2013, 13, 453–460. [Google Scholar] [CrossRef] [PubMed]
- Biondo, C.; Mancuso, G.; Beninati, C.; Iaria, C.; Romeo, O.; Cascio, A.; Teti, G. The role of endosomal toll-like receptors in bacterial recognition. Eur. Rev. Med. Pharmacol. Sci. 2012, 16, 1506–1512. [Google Scholar] [PubMed]
- Eisner, M.D.; Anthonisen, N.; Coultas, D.; Kuenzli, N.; Perez-Padilla, R.; Postma, D.; Romieu, I.; Silverman, E.K.; Balmes, J.R.; Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2010, 182, 693–718. [Google Scholar] [CrossRef] [PubMed]
- Henson, P.M.; Tuder, R.M. Apoptosis in the lung: Induction, clearance and detection. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294, L601–L611. [Google Scholar] [CrossRef] [PubMed]
- Salvi, S.S.; Barnes, P.J. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009, 374, 733–743. [Google Scholar] [CrossRef]
- Barnes, P.J. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 2016, 138, 16–27. [Google Scholar] [CrossRef] [PubMed]
- Russell, R.E.; Culpitt, S.V.; DeMatos, C.; Donnelly, L.; Smith, M.; Wiggins, J.; Barnes, P.J. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am. J. Respir. Cell. Mol. Biol. 2002, 26, 602–609. [Google Scholar] [CrossRef] [PubMed]
- Nakajima, T.; Nakamura, H.; Owen, C.A.; Yoshida, S.; Tsuduki, K.; Chubachi, S.; Shirahata, T.; Mashimo, S.; Nakamura, M.; Takahashi, S.; et al. Plasma Cathepsin S and Cathepsin S/Cystatin C ratios are potential biomarkers for COPD. Dis. Markers 2016, 2016, 4093870. [Google Scholar] [CrossRef] [PubMed]
- Global Strategy for the diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lungo Disease (GOLD). 2017. Available online: http://goldcopd.org (accessed on 20 December 2017).
- Zakharkina, T.; Koczulla, A.R.; Mardanova, O.; Hattesohl, A.; Bals, R. Detection of microorganisms in exhaled breath condensate during acute exacerbations of COPD. Respirology 2011, 16, 932–938. [Google Scholar] [CrossRef] [PubMed]
- Donnelly, L.E.; Barnes, P.J. Defective phagocytosis in airways disease. Chest 2012, 141, 1055–1062. [Google Scholar] [CrossRef] [PubMed]
- Mammen, M.J.; Sethi, S. COPD and the microbiome. Respirology 2016, 21, 590–599. [Google Scholar] [CrossRef] [PubMed]
- Berenson, C.S.; Kruzel, R.L.; Eberhardt, E.; Sethi, S. Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease. J. Infect. Dis. 2013, 208, 2036–2045. [Google Scholar] [CrossRef] [PubMed]
- Naito, K.; Yamasaki, K.; Yatera, K.; Akata, K.; Noguchi, S.; Kawanami, T.; Fukuda, K.; Kido, T.; Ishimoto, H.; Mukae, H. Bacteriological incidence in pneumonia patients with pulmonary emphysema: A bacterial floral analysis using the 16S ribosomal RNA gene in bronchoalveolar lavage fluid. Int. J. Chronic Obstr. Pulm. Dis. 2017, 12, 2111–2120. [Google Scholar] [CrossRef] [PubMed]
- Takahashi, S.; Ishii, M.; Namkoong, H.; Hegab, A.E.; Asami, T.; Yagi, K.; Sasaki, M.; Haraguchi, M.; Sato, M.; Kameyama, N.; et al. Pneumococcal infection aggravates elastase-induced emphysema via matrix metalloproteinase 12 overexpression. J. Infect. Dis. 2016, 213, 1018–1030. [Google Scholar] [CrossRef] [PubMed]
- Kirkham, P.A.; Spooner, G.; Rahman, I.; Rossi, A.G. Macrophage phagocytosis of apoptotic neutrophils is compromised by matrix proteins modified by cigarette smoke and lipid peroxidation products. Biochem. Biophys. Res. Commun. 2004, 318, 32–37. [Google Scholar] [CrossRef] [PubMed]
- Simpson, J.L.; Gibson, P.G.; Yang, I.A.; Upham, J.; James, A.; Reynolds, P.N.; Hodge, S. AMAZES Study Research Group. Impaired macrophage phagocytosis in non-eosinophilic asthma. Clin. Exp. Allergy 2013, 43, 29–35. [Google Scholar] [CrossRef] [PubMed]
- Pandey, K.C.; De, S.; Mishra, P.K. Role of proteases in chronic obstructive pulmonary disease. Front. Pharmacol. 2017, 8, 512. [Google Scholar] [CrossRef] [PubMed]
- Brinkmann, V.; Reichard, U.; Goosmann, C.; Fauler, B.; Uhlemann, Y.; Weiss, D.S.; Weinrauch, Y.; Zychlinsky, A. Neutrophil extracellular traps kill bacteria. Science 2004, 303, 1532–1535. [Google Scholar] [CrossRef] [PubMed]
- Griffin, S.; Carroll, T.P.; Greene, C.M.; O’Neill, S.J.; Taggart, C.C.; McElvaney, N.G. Effect of pro-inflammatory stimuli on mucin expression and inhibition by secretory leucoprotease inhibitor. Cell. Microbiol. 2007, 9, 670–679. [Google Scholar] [CrossRef] [PubMed]
- Hodge, S.; Hodge, G.; Holmes, M.; Reynolds, P.N. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur. Respir. J. 2005, 25, 447–454. [Google Scholar] [CrossRef] [PubMed]
- Bazzan, E.; Turato, G.; Tine, M.; Radu, C.M.; Balestro, E.; Rigobello, C.; Biondini, D.; Schiavon, M.; Lunardi, F.; Baraldo, S.; et al. Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity. Respir. Res. 2017, 18, 40. [Google Scholar] [CrossRef] [PubMed]
- Osinska, I.; Wolosz, D.; Domagala-Kulawik, J. Association between M1 and M2 macrophages in bronchoalveolar lavage fluid and tobacco smoking in patients with sarcoidosis. Pol. Arch. Med. Wewn. 2014, 124, 359–364. [Google Scholar] [CrossRef] [PubMed]
- Mills, C.D.; Thomas, A.C.; Lenz, L.L.; Munder, M. Macrophage: SHIP of immunity. Front. Immunol. 2014, 5, 620. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Genin, M.; Clement, F.; Fattaccioli, A.; Raes, M.; Michiels, C. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer 2015, 15, 577. [Google Scholar] [CrossRef] [PubMed]
- Eapen, M.S.; Hansbro, P.M.; McAlinden, K.; Kim, R.Y.; Ward, C.; Hackett, T.L.; Walters, E.H.; Sohal, S.S. Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD). Sci. Rep. 2017, 7, 13392. [Google Scholar] [CrossRef] [PubMed]
- Hodge, S.; Hodge, G.; Ahern, J.; Jersmann, H.; Holmes, M.; Reynolds, P.N. Smoking alters alveolar macrophage recognition and phagocytic ability: Implications in chronic obstructive pulmonary disease. Am. J. Respir. Cell. Mol. Biol. 2007, 37, 748–755. [Google Scholar] [CrossRef] [PubMed]
- Hodge, S.; Hodge, G.; Scicchitano, R.; Reynolds, P.N.; Holmes, M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol. Cell Biol. 2003, 81, 289–296. [Google Scholar] [CrossRef] [PubMed]
- Vecchiarelli, A.; Dottorini, M.; Puliti, M.; Todisco, T.; Cenci, E.; Bistoni, F. Defective candidacidal activity of alveolar macrophages and peripheral blood monocytes from patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1991, 143, 1049–1054. [Google Scholar] [CrossRef] [PubMed]
- Ferrara, F.; D’Adda, D.; Falchi, M.; Dall’Asta, L. The macrophagic activity of patients affected by pneumonia or chronic obstructive pulmonary disease. Int. J. Tissue React. 1996, 18, 109–114. [Google Scholar] [PubMed]
- Wu, Y.; Xu, H.; Li, L.; Yuan, W.; Zhang, D.; Huang, W. Susceptibility to Aspergillus infections in rats with chronic obstructive pulmonary disease via deficiency function of alveolar macrophages and impaired activation of TLR2. Inflammation 2016, 39, 1310–1318. [Google Scholar] [CrossRef] [PubMed]
- Berenson, C.S.; Garlipp, M.A.; Grove, L.J.; Maloney, J.; Sethi, S. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J. Infect. Dis. 2006, 194, 1375–1384. [Google Scholar] [CrossRef] [PubMed]
- Ween, M.; Ahern, J.; Carroll, A.; Hodge, G.; Pizzutto, S.; Jersmann, H.; Reynolds, P.; Hodge, S. A small volume technique to examine and compare alveolar macrophage phagocytosis of apoptotic cells and non typeable Haemophilus influenzae (NTHi). J. Immunol. Methods 2016, 429, 7–14. [Google Scholar] [CrossRef] [PubMed]
- Taylor, A.E.; Finney-Hayward, T.K.; Quint, J.K.; Thomas, C.M.; Tudhope, S.J.; Wedzicha, J.A.; Barnes, P.J.; Donnelly, L.E. Defective macrophage phagocytosis of bacteria in COPD. Eur. Respir. J. 2010, 35, 1039–1047. [Google Scholar] [CrossRef] [PubMed]
- Oliver, B.G.; Lim, S.; Wark, P.; Laza-Stanca, V.; King, N.; Black, J.L.; Burgess, J.K.; Roth, M.; Johnston, S.L. Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Thorax 2008, 63, 519–525. [Google Scholar] [CrossRef] [PubMed]
- Richens, T.R.; Linderman, D.J.; Horstmann, S.A.; Lambert, C.; Xiao, Y.Q.; Keith, R.L.; Boe, D.M.; Morimoto, K.; Bowler, R.P.; Day, B.J.; et al. Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. Am. J. Respir. Crit. Care Med. 2009, 179, 1011–1021. [Google Scholar] [CrossRef] [PubMed]
- Mukaro, V.R.; Bylund, J.; Hodge, G.; Holmes, M.; Jersmann, H.; Reynolds, P.N.; Hodge, S. Lectins offer new perspectives in the development of macrophage-targeted therapies for COPD/emphysema. PLoS ONE 2013, 8, e56147. [Google Scholar] [CrossRef] [PubMed]
- Bewley, M.A.; Belchamber, K.B.; Chana, K.K.; Budd, R.C.; Donaldson, G.; Wedzicha, J.A.; Brightling, C.E.; Kilty, I.; Donnelly, L.E.; Barnes, P.J.; et al. Differential effects of p38, MAPK, PI3K or Rho kinase inhibitors on bacterial phagocytosis and efferocytosis by macrophages in COPD. PLoS ONE 2016, 11, e0163139. [Google Scholar] [CrossRef] [PubMed]
- Hodge, S.; Hodge, G.; Brozyna, S.; Jersmann, H.; Holmes, M.; Reynolds, P.N. Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages. Eur. Respir. J. 2006, 28, 486–495. [Google Scholar] [CrossRef] [PubMed]
- Hodge, S.; Hodge, G.; Jersmann, H.; Matthews, G.; Ahern, J.; Holmes, M.; Reynolds, P.N. Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2008, 178, 139–148. [Google Scholar] [CrossRef] [PubMed]
- Hodge, S.; Reynolds, P.N. Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophages in chronic obstructive pulmonary disease subjects. Respirology 2012, 17, 802–807. [Google Scholar] [CrossRef] [PubMed]
- Hodge, S.; Tran, H.B.; Hamon, R.; Roscioli, E.; Hodge, G.; Jersmann, H.; Ween, M.; Reynolds, P.N.; Yeung, A.; Treiberg, J.; et al. Nonantibiotic macrolides restore airway macrophage phagocytic function with potential anti-inflammatory effects in chronic lung diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 2017, 312, L678–L687. [Google Scholar] [CrossRef] [PubMed]
- Segal, L.N.; Clemente, J.C.; Wu, B.G.; Wikoff, W.R.; Gao, Z.; Li, Y.; Ko, J.P.; Rom, W.N.; Blaser, M.J.; Weiden, M.D. Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung. Thorax 2017, 72, 13–22. [Google Scholar] [CrossRef] [PubMed]
- Singh, S.; Amin, A.V.; Loke, Y.K. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: A meta-analysis. Arch. Intern. Med. 2009, 169, 219–229. [Google Scholar] [CrossRef] [PubMed]
- Sin, D.D.; Tashkin, D.; Zhang, X.; Radner, F.; Sjobring, U.; Thoren, A.; Calverley, P.M.; Rennard, S.I. Budesonide and the risk of pneumonia: A meta-analysis of individual patient data. Lancet 2009, 374, 712–719. [Google Scholar] [CrossRef]
- Yang, M.; Chen, H.; Zhang, Y.; Du, Y.; Xu, Y.; Jiang, P.; Xu, Z. Long-term use of inhaled corticosteroids and risk of upper respiratory tract infection in chronic obstructive pulmonary disease: A meta-analysis. Inhal. Toxicol. 2017, 29, 219–226. [Google Scholar] [CrossRef] [PubMed]
- Stolberg, V.R.; McCubbrey, A.L.; Freeman, C.M.; Brown, J.P.; Crudgington, S.W.; Taitano, S.H.; Saxton, B.L.; Mancuso, P.; Curtis, J.L. Glucocorticoid-augmented efferocytosis inhibits pulmonary pneumococcal clearance in mice by reducing alveolar macrophage bactericidal function. J. Immunol. 2015, 195, 174–184. [Google Scholar] [CrossRef] [PubMed]
- Patterson, C.M.; Morrison, R.L.; D’Souza, A.; Teng, X.S.; Happel, K.I. Inhaled fluticasone propionate impairs pulmonary clearance of Klebsiella pneumoniae in mice. Respir. Res. 2012, 13, 40. [Google Scholar] [CrossRef] [PubMed]
- Morimoto, K.; Janssen, W.J.; Fessler, M.B.; McPhillips, K.A.; Borges, V.M.; Bowler, R.P.; Xiao, Y.Q.; Kench, J.A.; Henson, P.M.; Vandivier, R.W. Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J. Immunol. 2006, 176, 7657–7665. [Google Scholar] [CrossRef] [PubMed]
- Bain, W.G.; Tripathi, A.; Mandke, P.; Gans, J.H.; D’Alessio, F.R.; Sidhaye, V.K.; Aggarwal, N.R. Low-dose oxygen enhances macrophage-derived bacterial clearance following cigarette smoke exposure. J. Immunol. Res. 2016, 2016, 1280347. [Google Scholar] [CrossRef] [PubMed]
- Serban, K.A.; Petrusca, D.N.; Mikosz, A.; Poirier, C.; Lockett, A.D.; Saint, L.; Justice, M.J.; Twigg, H.L., 3rd; Campos, M.A.; Petrache, I. Alpha-1 antitrypsin supplementation improves alveolar macrophages efferocytosis and phagocytosis following cigarette smoke exposure. PLoS ONE 2017, 12, e0176073. [Google Scholar] [CrossRef] [PubMed]
- Walton, G.M.; Stockley, J.A.; Griffiths, D.; Sadhra, C.S.; Purvis, T.; Sapey, E. Repurposing treatments to enhance innate immunity. Can statins improve neutrophil functions and clinical outcomes in COPD? J. Clin. Med. 2016, 5, E89. [Google Scholar] [CrossRef] [PubMed]
- Maneechotesuwan, K.; Wongkajornsilp, A.; Adcock, I.M.; Barnes, P.J. Simvastatin suppresses airway IL-17 and upregulates IL-10 in patients with stable COPD. Chest 2015, 148, 1164–1176. [Google Scholar] [CrossRef] [PubMed]
- Eltboli, O.; Bafadhel, M.; Hollins, F.; Wright, A.; Hargadon, B.; Kulkarni, N.; Brightling, C. COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils. BMC Pulm. Med. 2014, 14, 112. [Google Scholar] [CrossRef] [PubMed]
- Croasdell, A.; Thatcher, T.H.; Kottmann, R.M.; Colas, R.A.; Dalli, J.; Serhan, C.N.; Sime, P.J.; Phipps, R.P. Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 2015, 309, L888–L901. [Google Scholar] [CrossRef] [PubMed]
- Hsiao, H.M.; Sapinoro, R.E.; Thatcher, T.H.; Croasdell, A.; Levy, E.P.; Fulton, R.A.; Olsen, K.C.; Pollock, S.J.; Serhan, C.N.; Phipps, R.P.; et al. A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation. PLoS ONE 2013, 8, e58258. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Noda, N.; Matsumoto, K.; Fukuyama, S.; Asai, Y.; Kitajima, H.; Seki, N.; Matsunaga, Y.; Kan, O.K.; Moriwaki, A.; Morimoto, K.; et al. Cigarette smoke impairs phagocytosis of apoptotic neutrophils by alveolar macrophages via inhibition of the histone deacetylase/Rac/CD9 pathways. Int. Immunol. 2013, 25, 643–650. [Google Scholar] [CrossRef] [PubMed]
- Martorana, P.A.; Lunghi, B.; Lucattelli, M.; De Cunto, G.; Beume, R.; Lungarella, G. Effect of roflumilast on inflammatory cells in the lungs of cigarette smoke-exposed mice. BMC Pulm. Med. 2008, 8, 17. [Google Scholar] [CrossRef] [PubMed]
- Vrancic, M.; Banjanac, M.; Nujic, K.; Bosnar, M.; Murati, T.; Munic, V.; Stupin Polancec, D.; Belamaric, D.; Parnham, M.J.; Erakovic Haber, V. Azithromycin distinctively modulates classical activation of human monocytes in vitro. Br. J. Pharmacol. 2012, 165, 1348–1360. [Google Scholar] [CrossRef] [PubMed]
- Buenestado, A.; Chaumais, M.C.; Grassin-Delyle, S.; Risse, P.A.; Naline, E.; Longchampt, E.; Tenor, H.; Devillier, P. Roflumilast inhibits lipopolysaccharide-induced tumor necrosis factor-alpha and chemokine production by human lung parenchyma. PLoS ONE 2013, 8, e74640. [Google Scholar] [CrossRef] [PubMed]
- Heulens, N.; Korf, H.; Cielen, N.; De Smidt, E.; Maes, K.; Gysemans, C.; Verbeken, E.; Gayan-Ramirez, G.; Mathieu, C.; Janssens, W. Vitamin D deficiency exacerbates COPD-like characteristics in the lungs of cigarette smoke-exposed mice. Respir. Res. 2015, 16, 110. [Google Scholar] [CrossRef] [PubMed]
- Ueno, M.; Maeno, T.; Nishimura, S.; Ogata, F.; Masubuchi, H.; Hara, K.; Yamaguchi, K.; Aoki, F.; Suga, T.; Nagai, R.; et al. Alendronate inhalation ameliorates elastase-induced pulmonary emphysema in mice by induction of apoptosis of alveolar macrophages. Nat. Commun. 2015, 6, 6332. [Google Scholar] [CrossRef] [PubMed]
- Tran, H.B.; Ahern, J.; Hodge, G.; Holt, P.; Dean, M.M.; Reynolds, P.N.; Hodge, S. Oxidative stress decreases functional airway mannose binding lectin in COPD. PLoS ONE 2014, 9, e98571. [Google Scholar] [CrossRef] [PubMed]
- Thimmulappa, R.K.; Gang, X.; Kim, J.H.; Sussan, T.E.; Witztum, J.L.; Biswal, S. Oxidized phospholipids impair pulmonary antibacterial defenses: Evidence in mice exposed to cigarette smoke. Biochem. Biophys. Res. Commun. 2012, 426, 253–259. [Google Scholar] [CrossRef] [PubMed]
- Aaron, S.D.; Vandemheen, K.L.; Maltais, F.; Field, S.K.; Sin, D.D.; Bourbeau, J.; Marciniuk, D.D.; FitzGerald, J.M.; Nair, P.; Mallick, R. TNF alpha antagonists for acute exacerbations of COPD: A randomised double-blind controlled trial. Thorax 2013, 68, 142–148. [Google Scholar] [CrossRef] [PubMed]
- Suissa, S.; Ernst, P.; Hudson, M. TNF-alpha antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease. Pulm. Pharmacol. Ther. 2008, 21, 234–238. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yamasaki, K.; Eeden, S.F.v. Lung Macrophage Phenotypes and Functional Responses: Role in the Pathogenesis of COPD. Int. J. Mol. Sci. 2018, 19, 582. https://doi.org/10.3390/ijms19020582
Yamasaki K, Eeden SFv. Lung Macrophage Phenotypes and Functional Responses: Role in the Pathogenesis of COPD. International Journal of Molecular Sciences. 2018; 19(2):582. https://doi.org/10.3390/ijms19020582
Chicago/Turabian StyleYamasaki, Kei, and Stephan F. van Eeden. 2018. "Lung Macrophage Phenotypes and Functional Responses: Role in the Pathogenesis of COPD" International Journal of Molecular Sciences 19, no. 2: 582. https://doi.org/10.3390/ijms19020582